Everolimus: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

30 May 2024

  • curprev 15:3615:36, 30 May 2024‎ Ai talk contribs‎ 7,228 bytes +7,228‎ Created page with "== Introduction == '''Everolimus''' is a derivative of sirolimus, an immunosuppressant drug used to prevent organ rejection and to treat various types of cancer. It is marketed under the trade names Afinitor and Zortress, among others. Everolimus is a mammalian target of rapamycin (mTOR) inhibitor, which plays a crucial role in regulating cell growth, proliferation, and survival. This article delves into the pharmacology, clinical applications, mechanisms of action,..."
Retrieved from "https://canonica.ai/page/Everolimus"